Aim To investigate the effects of continuous intrathecal baclofen (ITB) therapy in children
with cerebral palsy (CP) and other neurological conditions. Method This systematic review …

Background Intrathecal baclofen (ITB) is a treatment modality used to improve the quality of
life of patients with intractable spasticity and dystonia. Although it is an effective solution in …

Introduction: Spasticity is a complex problem in patients with neurological disorders and may
distress their quality of life. Intrathecal baclofen infusion pumps reduce spasticity with low …

Purpose Intrathecal baclofen (ITB) treatment is used with increasing frequency in the
cerebral palsy population. We describe the complications of ITB treatment, the incidence of …

Purpose To assess the complication risks associated with intrathecal baclofen (ITB) pumps
in cerebral palsy (CP) patients undergoing posterior spinal fusion (PSF) and to determine if …

Intrathecal baclofen (ITB) therapy effectively treats spasticity caused by brain or spinal cord
lesions. However, only a few studies compare the course of treatment for different diseases …

In recent years, intrathecal baclofen (ITB) has attained an important role in the treatment of
severe spasticity and dystonia in children. There are principal differences between the use …

Background: Neurosurgical indications and interventions provided in the management of
spasticity have evolved significantly over time. Selective dorsal rhizotomy (SDR) and …

Background Spasticity can significantly affect a patient's quality of life, caregiver satisfaction,
and the financial burden on the healthcare system. Baclofen is one of only a few options for …

Spasticity can cause muscle stiffness, pain, and discomfort, as well as decreased function.
The muscles of individuals with cerebral palsy (CP) are smaller, weaker, and have distinct …